Dr. Jad WAKIM
Faculty of Medicine
Lecturer
(+961) 1 421 000 ext 71911411 jad.wakim2@usj.edu.lb
Dr Jad Wakim is a Hematologist-Oncologist trained at the University of Texas Southwestern its NCI-designated Comprehensive Cancer Center. He is double American Board Certified in Medical Oncology Hematology. Dr. Wakim was the Director of Sweetwater Cancer Center in Rock Springs, WY for 5 years, affiliated with the Huntsman Cancer Institute, before moving back to his native Lebanon where he joined Hotel-Dieu de France University Hospital Clemenceau Medical Center Affiliated with John Hopkins International. He is a lecturer at the University of Utah Saint Joseph University Faculty of Medicine. He has earned numerous awards for clinical achievements presentations, and has published many papers and book chapters
Highest degree : Medical Doctor (MD) with an American Board in Oncology & Hematology Specialization Diploma - University of Texas Southwestern Dallas TX - USA
+ Education
| Degrees | University | Country | Year |
|---|---|---|---|
| American Board of Hematology | ABIM/ABMS (American Board of Medical Specialties) | Etats-Unis | 2012 |
| Hematology-Oncology Fellow | University of Texas Southwestern Medical Center | Etats-Unis | 2012 |
| American Board of Medical Oncology | ABIM/ABMS (American Board of Medical Specialties) | Etats-Unis | 2012 |
| Internal Medicine Chief Resident | State University of New York Upstate (SUNY Upstate) | Etats-Unis | 2009 |
| Internal Medicine Residency | State University of New York Upstate (SUNY Upstate) | Etats-Unis | 2008 |
| American Board of Internal Medicine | ABIM | Etats-Unis | 2008 |
| Medical Doctor | Saint Joseph University of Beirut | Lebanon | 2004 |
+ Teaching outside USJ
| Experience in University Teaching Outside USJ | Country | Institution | Start Date | End Date |
|---|---|---|---|---|
| Internal Medicine & Hematology-Oncology Clinical Instructor, University of Utah, Huntsman Cancer Institute | United States of America | University of Utah, Huntsman Cancer Institute | 01/03/2015 | 30/06/2018 |
| Internal Medicine Chief Resident, SUNY Upstate Medical University Hospital | United States of America | SUNY Upstate Medical University Hospital | 01/07/2008 | 30/06/2009 |
+ Professionnal experience outside USJ
| Professional Experience | Organization | Start date | End date |
|---|---|---|---|
| Hematologist-Oncologist, Northern Light Health-Eastern Maine Medical Center, Bangor, ME, USA | Northern Light Health-Eastern Maine Medical Center, Bangor, ME | 01/01/2022 | 30/09/2024 |
| Hematologist-Oncologist, St Michael Hospital Cancer Center, Texarkana, TX, USA | St Michael Hospital Cancer Center, Texarkana, TX, USA | 01/07/2021 | 30/06/2022 |
| Hematologist-Oncologist, Hotel-Dieu de France University Hospital | Hotel-Dieu de France University Hospital | 01/04/2018 | 11/11/2024 |
| Hematologist-Oncologist, Clemenceau Medical Center | Clemenceau Medical Center | 01/10/2017 | 11/11/2024 |
| Medical Director, Hematologist-Oncologist, Sweetwater Regional Cancer Center, an Affiliate of Huntsman Cancer Institute, University of Utah, NCI-Designated Comprehensive Cancer Center | Sweetwater Regional Cancer Center, an Affiliate of Huntsman Cancer Institute, University of Utah, NCI-Designated Comprehensive Cancer Center | 01/08/2012 | 30/09/2017 |
+ Expertise field
Medecine and Health
+ Publications and communications
Genetic markers of chronic lymphocytic leukemia: a retrospective study of 312 patients from a reference center in Lebanon. Future Oncology 2023 Sep19(29):1991-2002.
Perceptions of the COVID-19 vaccine among patients with cancer: a single-institution survey. Future Oncology 2021 Nov 17(31):4071-4079.
Helou S., Helou E., Abou-Khalil V., Wakim J., et al. The effect of the COVID-19 pandemic on physicians’ use perception of telehealth: The case of Lebanon. Int. J. Environ. Res. Public Health 2020, 17, 4866
Chaudary P., Wakim J., Khadim H., Karumbaiah KK., Gajra A. Acquired factor X deficiency in systemic amyloidosis: management of two cases. Haemophilia, 2013 Nov 19(6): e375-6.
Wakim JJ., Levenson BM., Matthews D., Naina H. Management of an unusual case of intravascular large B-cell lymphoma of the penis, prostate, bones with CNS relapse. Journal of Clinical Oncology, 2013 June 1031(17):e288-9.
Wakim JJ., Tirado CA., Dowell J., and Chen W. The first case of Philadelphia-negative acute promyelocytic leukemia following imatinib for chronic myeloid leukemia. Cancer Genetics and Cytogenetics, 2012 March;205(3): p124-127.
Wakim JJ. and Tirado CA (January 2012). Acute promyelocytic leukemia lacking the classic translocation t(15;17). In: Koschmieder, S. and Krug, U. (Editors). Myeloid Leukemia – Clinical Diagnosis and Treatment. Chapter 12, p219-234. Intech.
Wakim JJ., Tirado CA., Chen W., and Collins R. t(8;22)/BCR-FGFR1 myeloproliferative disorder presenting as B-acute lymphoblastic leukemia: report of a case treated with sorafenib and review of the literature. Leukemia Research, 2011 Sep;35(9):e151-3